ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near New Haven, CT, USA:

Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Sanofi
Sanofi

New Haven, Connecticut, United States and 9 other locations

for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plu...

Enrolling
Type 1 Diabetes Mellitus
Drug: Technosphere Insulin
Drug: Basal insulin

Phase 2

MannKind
MannKind

New Haven, Connecticut, United States and 9 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Bridgeport, Connecticut, United States of America and 89 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Waterbury, Massachusetts, United States of America and 40 other locations

Locations recently updated

The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: Ribupatide
Drug: Placebo

Phase 3

Kailera

Stamford, Connecticut, United States and 115 other locations

This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insu...

Active, not recruiting
Type 2 Diabetes
Device: CGM
Dexcom
Dexcom

East Northport, New York, United States and 17 other locations

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling
Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
Drug: CNP-103
Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

Syosset, New York, United States and 34 other locations

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Begins enrollment in 1 month
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Stamford, Connecticut, United States and 70 other locations

can improve patient outcomes for people over the age of 50 with diabetic foot ulcers. The study aims to determine the incidence of complete ...

Enrolling
Diabetic Foot Ulcer
Device: Orion TM Amniotic Membrane Allograft
Procedure: Standard of Care (SOC)
Legacy Medical Consultants

Darien, Connecticut, United States and 7 other locations

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute...

Enrolling
Diabetes Secondary to Pancreatitis
Type 1 Diabetes (T1D)
Behavioral: Mindfulness app
Yale University
Yale University

New Haven, Connecticut, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems